Company Profile

Company Description

Iterum Therapeutics plc is a clinical-stage pharmaceutical company focused on developing innovative antibiotics to combat drug-resistant infections. Specializing in oral and intravenous treatments, it aims to address the growing global challenge of antimicrobial resistance. The company's lead candidate targets urinary tract infections caused by resistant pathogens, offering potential alternatives to existing therapies with limited efficacy. Its research emphasizes improving patient outcomes and reducing healthcare burdens associated with resistant infections. By advancing novel compounds, it seeks to fill critical gaps in infectious disease treatment, particularly for Gram-negative bacteria. The firm collaborates with regulatory agencies and researchers to bring effective solutions to market.